GABAA receptor antisense epilepsy: Histological changes following infusion of antisense oligodeoxynucleotide to GABAA receptor γ2 subunit rat hippocampus

Neurological Research

Volumn 23, Issue 1, 2001, Pages 39-46

  Karle, J ^a   Woldbye, D P D ^a   Diemer, N H ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Antisense; Hippocampus; Immunocytochemistry; Neurodegeneration; Oligodeoxy nucleotide; Status epilepticus; Temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; DIAGNOSTIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL PROLIFERATION; ELECTROGRAPHY; EPILEPTOGENESIS; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HYPERTROPHY; HYPOTHESIS; IMMUNOCYTOCHEMISTRY; INFUSION; MACROGLIA; MACROPHAGE; MONOCYTE; NERVE DEGENERATION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BINDING; SEIZURE; TEMPORAL LOBE EPILEPSY; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EPILEPSY; GENETICS; MALE; METABOLISM; NERVE CELL INHIBITION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEURAL INHIBITION; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTORS, GABA-A; TIME FACTORS;

EID: 0034746422     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164101101198262     Document Type: Article

References (39)

1. A receptor subtypes
2. A receptors
3. GABA and epileptogenesis
4. Pharmacological inhibition of dopaminergic and other neurotransmitter receptors using antisense oligodeoxynucleotides
5. Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: Some prospects and problems
6. A receptor γ2 subunit induces limbic status epilepticus
7. A receptor γ2 subunit induces loss of neurones in rat hippocampus
8. A receptor γ2 subunit
9. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy
10. Status epilepticus
11. Do nonconvulsive seizures damage the brain? - Yes
12. Induction of astroglial gene expression by experimental seizures in the rat: Spatio-temporal patterns of the early stages
13. A receptor subunits exist in distinct neuronal subpopulations
14. A receptor γ2 subunit
15. The temporal evolution of hypoglycemic brain damage. I. Light and electron microscopic findings in the rat cerebral cortex
16. Antisense oligodeoxyribonucleotides: Stability and distribution after intracerebral injection into rat brain
17. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization
18. Antisense targeting in behavioural neuroendocrinology
19. The application of antisense oligonucleotide technology to the brain: Some pitfalls
20. Antisense oligonucleotides in neuroendocrinology: Enthusiasm and frustration
21. Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system
22. 1A receptor
23. Intracerebroventricular administration of missense oligodeoxynucleotide induces interleukin-6 mRNA expression in brain and spleen of rats
24. Centrally administered oligodeoxynucleotides in rats: Occurrence of non-specific effects
25. Epilepsy
26. On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of humans and experimental animals
27. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
28. Kainic acid seizures in the rat
29. Histopathological and immunohistochemical changes in neurosurgically resected epileptic foci
30. Biochemical correlates of epilepsy in the E1 mouse: Analysis of glial fibrillary acidic protein and gangliosides
31. Increase in GAP-43 and GFAP immunoreactivity in the rat hippocampus subsequent to perforant path kindling
32. A receptor γ2 subunit in rat hippocampus
33. A receptor γ2 subunit enhances neuropeptide Y (NPY) gene expression
34. Loss of somatal neuropeptide Y immunoreactivity in the rat hippocampus following transient cerebral ischemia
35. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation
36. Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat
37. Knockout mice reveal a critical anti-epileptic role for neuropeptide Y
38. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors